Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

AF EP procedure volumes to grow by 25 percent

Millennium Research Group : 21 March, 2008  (Company News)
More than 32,000 electrophysiology (EP) procedures were performed for the treatment of AF in the USA in 2007 according to a report from the Millennium Research Group.
The report entitled ‘Global Markets for Atrial Fibrillation (AF) Treatment Devices 2008’ estimates that AF EP procedure volumes will increase at a compound annual growth rate of over 25 percent from 2008 to 2012.

Growth in procedure volumes will be driven by the increasing physician acceptance of EP ablation as a viable and effective treatment for AF. Over the next several years, these procedures will be used more often over medical therapy than in the past. The introduction of new technology will also support greater procedure volumes through 2012; these new devices will enable physicians to increase the safety, efficiency, and efficacy of EP ablation Catheter procedures. By 2012, over 109,000 EP procedures will be performed to treat AF in the USA.

'The patient pool that hasn't been treated in this market is huge and growing,' said Andrew Wong, analyst at Millennium Research Group. 'Almost three million people have atrial fibrillation in the USA, but currently only about 100,000 are being treated annually.'

The’Global Markets for Atrial Fibrillation Treatment Devices 2008’ report includes coverage of the AF EP, cardiac rhythm management, and surgical ablation device markets. The report provides coverage of US, Europe, and Japan and all key industry competitors, including Biosense Webster, Boston Scientific, Medtronic, and St Jude Medical.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo